Method of identifying disease risk factors

Details for Australian Patent Application No. 2009282114 (hide)

Owner Shiraz Pharmaceuticals, Inc.

Inventors Roses, Allen D.

Agent Griffith Hack

Pub. Number AU-A-2009282114

PCT Pub. Number WO2010/019550

Priority 61/088,203 12.08.08 US; 61/186,673 12.06.09 US; 61/224,647 10.07.09 US

Filing date 11 August 2009

Wipo publication date 18 February 2010

International Classifications

G01N 33/48 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Biological material, e.g. blood, urine

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

Event Publications

10 March 2011 PCT application entered the National Phase

  PCT publication WO2010/019550 Priority application(s): WO2010/019550

7 April 2011 Alteration of Name

  The name of the applicant has been altered to Zinfandel Pharmaceuticals, Inc.

28 April 2011 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 21 Mar 2011

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009282115-High-solvency-dispersive-power (HSDP) crude oil blending for fouling mitigation and on-line cleaning

2009282112-Method and apparatus for reducing fouling using resid fractions of high tan and high SBN crude oil